Results 271 to 280 of about 880,908 (352)

Development and Application of Organic Sonosensitizers in Cancer Therapy

open access: yesAggregate, EarlyView.
This review provides a comprehensive overview of organic sonosensitizers employed in cancer treatment, describing their underlying mechanisms and structure‐activity relationship in terms of sonodynamic therapy. The significance of nanotechnology and combination therapy with other oncological modalities (photothermal therapy, photodynamic therapy, etc.)
Yuhan Ding   +5 more
wiley   +1 more source

iPRISM: Intelligent Predicting Response to Cancer Immunotherapy through Systematic Modeling

open access: yesAdvanced Intelligent Systems, EarlyView.
The Intelligent Predicting Response to cancer Immunotherapy through Systematic Modeling (iPRISM) model uses data from genes and immune responses to predict how well cancer patients will respond to immunotherapy. Tested on multiple cancer types, iPRISM shows higher accuracy compared to existing methods.
Yinchun Su   +7 more
wiley   +1 more source

Effect of delayed isolation of peripheral blood mononuclear cells on cell viability and functionality. [PDF]

open access: yesBMC Immunol
Lehle S   +11 more
europepmc   +1 more source

TP53‐Mutated Myeloid Neoplasms: 2024 Update on Diagnosis, Risk‐Stratification, and Management

open access: yesAmerican Journal of Hematology, EarlyView.
ABSTRACT Alterations in the tumor suppressor gene TP53 are common in human cancers and are associated with an aggressive nature. Approximately 8%–12% of myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML) harbor TP53 mutations (TP53mut) and present immense challenges due to inherent chemoresistance and poor outcomes.
Mithun Vinod Shah   +2 more
wiley   +1 more source

High-throughput drug screening identifies SMAC mimetics as enhancers of NK-cell cytotoxicity in chronic myeloid leukemia.

open access: yesBlood
Nygrén P   +18 more
europepmc   +1 more source

NK Count and Natural Cytotoxicity in Immune Nonresponders Versus Responders Living With HIV. [PDF]

open access: yesJ Med Virol
Silvestre C   +8 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy